These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 13491891)

  • 1. Scleroderma (acrosclerosis). I. Treatment of three cases of the non-calcific variety by Chelation (EDTA).
    RUKAVINA JG; MENDELSON C; PRICE JM; BROWN RR; JOHNSON SA
    J Invest Dermatol; 1957 Oct; 29(4):273-88. PubMed ID: 13491891
    [No Abstract]   [Full Text] [Related]  

  • 2. Scleroderma (acrosclerosis). II. Tryptophan metabolism before and during treatment by Chelaton (EDTA).
    PRICE JM; BROWN RR; RUKAVINA JG; MENDELSON C; JOHNSON SA
    J Invest Dermatol; 1957 Oct; 29(4):289-98. PubMed ID: 13491892
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of scleroderma with the new chelating agent, edathamil.
    MULLER SA; BRUNSTING LA; WINKELMANN RK
    AMA Arch Derm; 1959 Aug; 80(2):187-94. PubMed ID: 13669744
    [No Abstract]   [Full Text] [Related]  

  • 4. [1st therapeutic trials of "chelating agents" (EDTA) in cases of scleroderma and of other fibrosclerotic processes of the dermal connective tissues].
    AGOSTINI A; ZANCA A
    G Ital Dermatol; 1961; 102():85-106. PubMed ID: 13859615
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent occurrences in the therapy of a form of scleroderma: acrosclerosis].
    KAMINSKY A; KAPLAN A
    Sem Med; 1958 Aug; 113(6):261-6 passim. PubMed ID: 13602893
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sclerodactyly with digital and pre-rotular calcinosis (Thibierge-Weissenbach syndrome) preceded by Renaud's syndrome; results of treatment with a chelating agent (sodium salt of edathamil)].
    NICK J; CONTAMIN F; HARL JM; MORIN P
    Bull Mem Soc Med Hop Paris; 1957 Feb 1-15; 73(4-6):169-74. PubMed ID: 13413679
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progressive scleroderma with considerable electromyographical changes treated with chelating agents (E.D.T.A.)].
    da FONSECA
    J Med (Oporto); 1960 Feb; 41():469-76. PubMed ID: 13823810
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the therapy of systematized scleropathy (progressive scleroderma) and systematized sarcoidosis with the chelating agent Na2EDTA].
    LANGHOF H; ZABEL H
    Dtsch Gesundheitsw; 1962 Feb; 17():188-97. PubMed ID: 14462154
    [No Abstract]   [Full Text] [Related]  

  • 9. A technique for intravenous therapy in patients with scleroderma and in apprehensive children.
    LUNDY JS
    AMA Arch Derm; 1959 Aug; 80(2):226-7. PubMed ID: 13669755
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic sclerosis. Fourteen cases treated with chelation (disodium EDTA) and/or pyridoxine, with comments on the possible role of altered tryptophan metabolism in pathogenesis.
    BIRK RE; RUPE CE
    Henry Ford Hosp Med Bull; 1962 Dec; 10():523-53. PubMed ID: 13968436
    [No Abstract]   [Full Text] [Related]  

  • 11. EDTA chelation for calcific band keratopathy.
    Arjamaa O
    Am J Ophthalmol; 2005 Jan; 139(1):216; author reply 216. PubMed ID: 15652866
    [No Abstract]   [Full Text] [Related]  

  • 12. 2 New cases of scleroderma treated by disodium tetracemate.
    THIERS H; COLOMB D; FAYOLLE J; MOULIN G; TAINE B
    Lyon Med; 1958 Jan; 90(2):49-50. PubMed ID: 13515532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Two more cases of scleroderma treated with disodium tetracemate].
    THIERS H; COLOMB D; FAYOLLE J; MOULIN G; TAINE B
    Bull Soc Fr Dermatol Syphiligr; 1957; 39(4):446-7. PubMed ID: 13511053
    [No Abstract]   [Full Text] [Related]  

  • 14. Edathamil in the treatment of scleroderma and calcinosis cutis.
    WINDER PR; CURTIS AC
    Arch Dermatol; 1960 Nov; 82():732-6. PubMed ID: 13785770
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of an intravenous chelating agent, edathamil disodium (Na 2-EDTA), in 3 cases of sarcoidosis.
    RUKAVINA JG; ORKIN M; LYNCH FW
    J Invest Dermatol; 1958 Nov; 31(5):259-62. PubMed ID: 13598931
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of the chelating agent edathamil disodium in acrosclerosis, sarcoidosis and other skin conditions with comments on tryptophan metabolism in sarcoidosis.
    JOHNSON SA
    Wis Med J; 1960 Oct; 59():651-5. PubMed ID: 13790343
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chelation - therapeutic applications].
    Perrault M; Clavel B
    Rev Pathol Gen Physiol Clin; 1958 Apr; 58(697):519-49 discussion 549-53. PubMed ID: 13579827
    [No Abstract]   [Full Text] [Related]  

  • 18. [The therapy of scleroderma with chelating agents].
    NEJEDLY O; PIPER HG
    Hautarzt; 1960 Aug; 11():378-9. PubMed ID: 13728235
    [No Abstract]   [Full Text] [Related]  

  • 19. Scleroderma. An evaluation of treatment with disodium edetate.
    NELDNER KH; WINKELMANN RK; PERRY HO
    Arch Dermatol; 1962 Sep; 86():305-9. PubMed ID: 14478876
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of scleroderma by chelation].
    CORRALES H
    Rev Med Hondur; 1960; 28():84-7. PubMed ID: 13695652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.